Watching transformation of the Global Fund on its 10th anniversary

"Are we watching the rebirth of the troubled Global Fund to Fight Aids, Tuberculosis and Malaria, perhaps in a new, more U.S.-flavored guise?" Guardian health editor Sarah Boseley asks in her "Global Health Blog." She writes, "The Fund has been in the mire now for some time after revelations that some of its grants fell into corrupt hands, short of money and unable to agree new grants to developing countries badly in need of disease-fighting programs," adding, "But the dramatic events of the past few days suggest the Global Fund's fortunes might be on the turn as it hits its tenth anniversary."

Boseley writes, "An overhaul is underway, to ensure not just transparency but greater efficiency" and notes that the Global Fund Board on Monday approved a "Consolidated Transformation Plan." On Tuesday it appointed a new general manager, Gabriel Jaramillo, the Columbian-born Brazilian citizen who is a former chair and CEO of Sovereign Bank, and current Executive Director Michel Kazatchkine announced his resignation effective in mid-March, according to Boseley. Noting recent support for the Global Fund by Bill Gates and Secretary of State Hillary Clinton, she writes, "The Global Fund looks likely to carry on its important work under new management, but perhaps we should not be surprised if it has a bit less of a European flavor than it has done until now" (1/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rutgers study sheds light on how bedaquiline fights drug-resistant tuberculosis